Teva has eliminated the core RICO exposure in this case, removing a significant litigation overhang. Monitor the separate order on state-law claims for any remaining financial exposure. The ruling reinforces Teva's legal position in similar co-pay charity cases and removes a key uncertainty for the stock.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 3 $34.46entry
- T+1 · 4mo ago −0.09%α −1.89% · $34.43
- T+5 · 3mo ago +4.88%α +2.85% · $36.14
- T+20 · 3mo ago +4.61%α +3.38% · $36.05
- T+60 · 21d ago +17.18%α +15.40% · $40.38
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Teva won summary judgment dismissing United Healthcare's RICO claims as time-barred. The court held that storm warnings, including a 2005 WSJ article quoting a Teva executive, extensive media coverage, and the 2017 IRS investigation into Teva's Copaxone co-pay charity donations, put United on inquiry notice by November 2018, four years before it sued. The ruling eliminates material RICO exposure for Teva, though state-law claims remain pending in a separate order.
Court Ruling Details
Key Facts
- Teva's motion for summary judgment on statute-of-limitations grounds was GRANTED as to all federal RICO claims.
- The court found storm warnings existed by November 2018, including a 2005 WSJ article quoting a Teva executive, 2013-2017 media coverage, and the 2017 IRS investigation into Teva's donations to the Chronic Disease Fund (CDF) for Copaxone co-pays.
- The Teva-CDF donation agreement, publicly filed in 2017, explicitly stated CDF would use Teva donations to cover Copaxone co-pays and provide detailed weekly/monthly reports to Teva.
- The court held that United Healthcare, as a sophisticated insurer, should have known of these warnings and that its RICO claims were filed too late.
- State-law claims (fraudulent concealment, tortious interference, unjust enrichment, consumer protection) were addressed in a separate order and remain pending.
- No damages were awarded; the ruling eliminates the RICO claims entirely.
Financial Impact
RICO claims dismissed, no damages awarded. The complaint sought unspecified millions in alleged overpayments for Copaxone. State-law claims remain pending.
Risk Factors
- State-law claims remain pending and could still result in damages or settlement costs.
- The ruling may be appealed by United Healthcare to the Third Circuit.
- Other insurers may bring similar claims based on the same alleged conduct, though this ruling creates a strong statute-of-limitations defense.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-12221f377c-TEVA |
Track record
61 reports on TEVA
5 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 14 of 16 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers